Digital Content 
NEWS #PharmaBuzz
17 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/17/3257011/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Announces-FDA-Bioequivalence-Determination-by-Office-of-Generic-Drugs-for-NRx-s-Preservative-Free-Ketamine-Application.html
16 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/16/3256130/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Confirms-Path-to-New-Drug-Application-with-Real-World-Data-and-Broader-Proposed-Indication-for-NRX-100-ketamine-Following-Type-C-FDA-Meeting.html
18 Feb 2026
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-18-2026-14056.pdf
14 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/14/3218507/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Announces-70-000-Patient-Data-on-Real-World-Use-of-Ketamine-for-Treatment-of-Suicidal-Depression-to-be-Submitted-to-the-FDA-in-Support-of-NRX-100-Ap.html
02 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/02/3197945/0/en/NRx-Pharmaceuticals-Announces-US-Food-and-Drug-Administration-FDA-Receipt-of-ANDA-for-KETAFREE-a-Preservative-Free-IV-Ketamine.html
02 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/02/3160310/0/en/PharmaTher-Provides-Corporate-Update-on-Ketamine-Development-and-Commercial-Strategy.html
Share